Industries de la santé

Mulhouse, France et Cambridge, MA, le 27 novembre 2012 – Rhenovia Pharma, société biotechnologique spécialisée dans la biosimulation appliquée à la recherche de nouveaux médicaments pour le traitement de maladies neurodégénératives, neurologiques et psychiatriques, annonce aujourd’hui le dépôt de deux brevets pour son produit RHEpatch™, un timbre transdermique intelligent pour...

NAIROBI, 19 February 2013 – Many synthetic chemicals, untested for their disrupting effects on the hormone system, could have significant health implications according to the State of the Science of Endocrine Disrupting Chemicals, a new report by the United Nations Environment Programme (UNEP) and the World Health Organization (WHO).

The joint study calls for more research to understand fully...

HEIDELBERG, 15 February 2013 – Researchers from King’s College London have discovered that neuronal activity can stimulate tau release from healthy neurons in the absence of cell death. The results published by Diane Hanger and her colleagues in EMBO reports show that treatment of neurons with known biological signaling molecules increases the release of tau into the culture medium...

Journal of Endovascular Therapy – High-risk patients benefit from less invasive procedures. A stent-grafting technique for aortic aneurysms is now showing promise for such patients. Chimney stent-grafts bring blood to aortic branch vessels that are covered by standard aortic stent-grafts during endovascular aneurysm repair (EVAR). This study provides some of the longest term results...

HEIDELBERG, 12 February 2013 – How do you compare the impact of a researcher in chemistry or physics with a molecular biologist who may be working on similar projects? In an article published today in EMBO reports two experts support the use of citation indicators that are based on percentiles, a statistical parameter that allows for comparisons with a carefully defined group of reference...

India is the second diabetes capital of the world after China, with the treatment market growing at a double-digit year-on-year growth rate, presenting both domestic and Multinational Companies (MNCs) with promising opportunities, states a new report by healthcare experts GBI Research.

Diabetes represents a group of metabolic diseases, characterized by hyperglycemia resulting from...

5 February 2013 – EMBO and the Federation of European Biochemical Societies (FEBS) announce Geneviève Almouzni, deputy director of the Institut Curie in Paris, France, as the winner of the 2013 FEBS | EMBO Women in Science Award.

Professor Almouzni has been recognized for her outstanding contributions to research in the area of histones and chromatin, her engagement in promoting...

Novozymes acquires Iogen Bio-Products, industrial enzyme business of Ottawa-based Iogen Corporation for CAD 67.5 million (approximately DKK 370 million) and potential earn-out payments of up to CAD 12.5 million (approximately DKK 70 million). The deal provides Novozymes with all commercial rights to Iogen Bio-Products’ existing product portfolio, pipeline, facilities and know-how...

30 January 2013 – The Federation of European Biochemical Societies (FEBS), EMBO, and the French Society for Biochemistry and Molecular Biology will hold a joint conference for the life sciences in 2014. The FEBS–EMBO 2014 Conference will take place from the 30 August to 4 September at the Palais des Congrès in Paris, France.

The FEBS–EMBO 2014 Conference will be a unique...

Vitrines Sociétés

Voir toutes les vitrines